Taking people in ChinaNo phase
China Inherited Ventricular Arrhythmias Registry
Key facts
- Who runs it
- China National Center for Cardiovascular Diseases
- Where
- Beijing, ChinaSee the site
- Trial code
- Status
- Recruiting
- People taking part
- 500 people, planned
- Started
- 24 Oct 2017
- Expected to end
- 24 Oct 2027
- Type of study
- Observational
- Record updated
- 26 March 2019
Who can take part
- Age
- 1 hour to 90 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 2 criteriaShow less
Who can take part
- diagnosed as Brugada syndrome(Brs)、Long QT syndrome(LQTS)、Short QT syndrome(SQTS)、Early repolarization syndrome(ERS) or Catecholaminergic polymorphic ventricular tachycardia(CPVT)
Who cannot take part
- patients were enrolled by other clinical trials
Where in China
- China National Center for Cardiovascular DiseasesBeijing, ChinaContact: Yan YAO, MD, PhDTaking people
About the trial
What the trial wants to find out
This is an observational, prospective, multi-center registry, aiming at building a risk stratification for malignant inherited ventricular arrhythmias, including Brugada syndrome(Brs)、Long QT syndrome(LQTS)、Short QT syndrome(SQTS)、Early repolarization syndrome(ERS) and Catecholaminergic polymorphic ventricular tachycardia(CPVT). 500 participants will be recruited from 10 centers in China, with clinical data to be abstracted from medical records, and blood samples to be collected for finding related genes and promising risk indicators. The follow-up should be made every 6 months.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- China Inherited Ventricular Arrhythmias Registry, a Multicenter, Observational and Prospective Study
- Record updated
- 26 March 2019